| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating Epidermal Growth Factor Receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum double chemotherapy: a meta-analysis of prospective randomized trials |
| 掲載誌名 | 正式名:The Oncologist 略 称:Oncologist ISSNコード:10837159/1549490X |
| 巻・号・頁 | 20(3),pp.307-315 |
| 著者・共著者 | Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa SI, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH |
| 発行年月 | 2015/03 |
| DOI | 10.1634/theoncologist.2014-0285 |
| 文献番号 | 25657199 |
| PMID | 25657199 |